BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ji M, Jin A, Sun J, Cui X, Yang Y, Chen L, Lin Z. Clinicopathological implications of NQO1 overexpression in the prognosis of pancreatic adenocarcinoma. Oncol Lett. 2017;13:2996-3002. [PMID: 28521407 DOI: 10.3892/ol.2017.5821] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhong B, Yu J, Hou Y, Ai N, Ge W, Lu JJ, Chen X. A novel strategy for glioblastoma treatment by induction of noptosis, an NQO1-dependent necrosis. Free Radic Biol Med 2021;166:104-15. [PMID: 33600944 DOI: 10.1016/j.freeradbiomed.2021.02.014] [Reference Citation Analysis]
2 Srijiwangsa P, Ponnikorn S, Na-Bangchang K. Effect of β-Eudesmol on NQO1 suppression-enhanced sensitivity of cholangiocarcinoma cells to chemotherapeutic agents. BMC Pharmacol Toxicol 2018;19:32. [PMID: 29914576 DOI: 10.1186/s40360-018-0223-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
3 Walia HK, Singh N, Sharma S. Association of NQO1Pro187Ser polymorphism with clinical outcomes and survival of lung cancer patients treated with platinum chemotherapy. Per Med 2021;18:333-46. [PMID: 33973803 DOI: 10.2217/pme-2020-0119] [Reference Citation Analysis]
4 Chen X, Cao X, Xiao W, Li B, Xue Q. PRDX5 as a novel binding partner in Nrf2-mediated NSCLC progression under oxidative stress. Aging (Albany NY) 2020;12:122-37. [PMID: 31899687 DOI: 10.18632/aging.102605] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Koyasu S, Kobayashi M, Goto Y, Hiraoka M, Harada H. Regulatory mechanisms of hypoxia-inducible factor 1 activity: Two decades of knowledge. Cancer Sci 2018;109:560-71. [PMID: 29285833 DOI: 10.1111/cas.13483] [Cited by in Crossref: 77] [Cited by in F6Publishing: 76] [Article Influence: 19.3] [Reference Citation Analysis]
6 Guo Y, Xu L, Ling C, Yang T, Zheng W, Lv J, Guo Q, Chen B. Novel β‐carboline‐based indole‐4,7‐quinone derivatives as NAD(P)H: Quinone‐oxidoreductase‐1 inhibitor with potent antitumor activities by inducing reactive oxygen species, apoptosis, and DNA damage. Chem Biol Drug Des 2020;96:1433-46. [DOI: 10.1111/cbdd.13752] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Wu Z, Wang Q, Yang H, Wang J, Li W, Liu G, Yang Y, Zhao Y, Tang Y. Discovery of Natural Products Targeting NQO1 via an Approach Combining Network-Based Inference and Identification of Privileged Substructures. J Chem Inf Model 2021;61:2486-98. [PMID: 33955748 DOI: 10.1021/acs.jcim.1c00260] [Reference Citation Analysis]
8 Deng GC, Sun DC, Zhou Q, Lv Y, Yan H, Han QL, Dai GH. Identification of DNA methylation-driven genes and construction of a nomogram to predict overall survival in pancreatic cancer. BMC Genomics 2021;22:791. [PMID: 34732125 DOI: 10.1186/s12864-021-08097-w] [Reference Citation Analysis]
9 Jiang ZN, Ahmed SMU, Wang QC, Shi HF, Tang XW. Quinone oxidoreductase 1 is overexpressed in gastric cancer and associated with outcome of adjuvant chemotherapy and survival. World J Gastroenterol 2021; 27(22): 3085-3096 [PMID: 34168410 DOI: 10.3748/wjg.v27.i22.3085] [Reference Citation Analysis]
10 Wang R, Cai K, Wang H, Yin C, Cheng J. A caged metabolic precursor for DT-diaphorase-responsive cell labeling. Chem Commun (Camb) 2018;54:4878-81. [PMID: 29700507 DOI: 10.1039/c8cc01715h] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Qian X, Chen Z, Chen SS, Liu LM, Zhang AQ. Integrated Analyses Identify Immune-Related Signature Associated with Qingyihuaji Formula for Treatment of Pancreatic Ductal Adenocarcinoma Using Network Pharmacology and Weighted Gene Co-Expression Network. J Immunol Res 2020;2020:7503605. [PMID: 32537471 DOI: 10.1155/2020/7503605] [Cited by in F6Publishing: 1] [Reference Citation Analysis]